Senators Request Probe Of FDA Conflict of Interest Waivers
This article was originally published in The Pink Sheet Daily
Executive Summary
Increasing concern over FDA advisory committee members’ conflicts of interest prompts Senators Enzi, Kennedy and Durbin to seek assistance from the Government Accountability Office in conducting a review of the policy.
You may also be interested in...
Plan B Language To Be Included In Conference Report On FDA Appropriations
Sen. Murray withdrew four amendments to the Ag Approps bill in exchange for a pledge that language will appear in the report expressing bipartisan concern over the emergency contraceptive’s review process.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.